| LEADER | 02579cam a22004214a 4500 | ||
|---|---|---|---|
| 001 | vtls000021732 | ||
| 003 | MY-ArUMP | ||
| 005 | 20210731231217.0 | ||
| 008 | 120302s2005 njua b 001 0 eng | ||
| 020 | |a 0471457140 |c RM339.80 | ||
| 035 | |a (OCoLC)ocm55633735 | ||
| 039 | 9 | |a 201203020952 |b SMT |c 201111291524 |d VLOAD |c 201111290955 |d VLOAD |c 200803150625 |d VLOAD |y 200511091659 |z JK |e MRM | |
| 040 | |a MYPMP |b eng |e rda |c MYPMP | ||
| 090 | 0 | 0 | |a TP248.65 |b P76I21 2005 |
| 245 | 0 | 0 | |a Industrial proteomics |b applications for biotechnology and pharmaceuticals / |c edited by Daniel Figeys. |
| 264 | 1 | |a Hoboken, N.J. |b Wiley |c c2005. | |
| 264 | 4 | |c ©2005 | |
| 300 | |a x, 303 pages |b illustrations |c 24 cm. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a unmediated |b n |2 rdamedia | ||
| 338 | |a volume |b nc |2 rdacarrier | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Proteomics: the basic overview / Daniel Figeys -- Mapping protein-protein interactions / Daniel Figeys -- Protein post-translational modifications: phosphorylation site analysis -- Using mass spectrometry / Roland S. Annan and Francesca Zappacosta -- The use of high throughput crystallography and in silico methods for -- Structure based drug design / Leslie W. Tarr, Andy J. Jennings, and Duncan E. McRee -- High throughput analysis of protein structure by H/D exchange (H/D-Ex) mass spectrometry / Yoshitomo Hamuro, Patricia C. Weber, and Patrick R. Griffin -- Proteomics technologies for identification and validation of protein targets / John E. Hale ... [et al.] -- Proteomics discovery of biomarkers / Robert Mass, and Bernard F. Gibbs -- Industrial-scale proteomics analysis of human plasma / Keith Rose -- Chemical genomics: targets on display / Steve Doberstein, Philip W. Hammond, and Ren S. Hubert -- Bioinformatics for proteomics / Christian Ahrens, Hans Jespersen, and Soeren Schandorff -- Protein arrays / David S. Wilson and Steffen Nock. | |
| 541 | |a Bajunaid Sdn Bhd | ||
| 591 | |a PER.2/OA/05/119f ( Selected by Dr. Harbant Singh) | ||
| 594 | |a 24-11-05 | ||
| 650 | 0 | |a Proteins |x Biotechnology. | |
| 650 | 0 | |a Proteomics. | |
| 650 | 1 | 2 | |a Proteomics. |
| 650 | 2 | 2 | |a Biotechnology. |
| 650 | 2 | 2 | |a Drug Industry. |
| 650 | 2 | 2 | |a Technology, Pharmaceutical. |
| 700 | 1 | |a Figeys, Daniel, |d 1968- | |
| 942 | |2 lcc |c BK-OS | ||
| 949 | |a VIRTUAITEM |d 10000 |f 1 |x 1 |6 019142 |9 1 | ||
| 985 | |a NLMCIP |d 2004-06-09 | ||
| 999 | |c 81340 |d 81340 | ||
| 952 | |0 0 |1 0 |2 lcc |4 0 |6 TP024865 P76 I21 02005 |7 0 |9 70853 |a PTSFP |b PTSFP |c 1 |d 2021-07-31 |o TP248.65 P76I21 2005 |p 019142 |r 2021-07-31 |t 1 |w 2021-07-31 |y BK-OS | ||